Updated hourlyHourly refreshWed, Oct 28, 2026
AI · SaaS
AI X Network introduces KnovaTwin to turn books and professional expertise into interactive courses taught by Digital Twins. KnovaTwin supports NVIDIA Nemotron 3.5 Lightning for course text generation. Free NVIDIA hosted API access is for testing and prototyping only; NVIDIA trial terms, rate limits and KnovaTwin plan terms apply. CCR provides the strategy framework across 15 chapters and 12 case studies. KnovaTwin e
Oct 26 · 23:10·EIN Presswire
Education · Food & drink
Drinking Tequila names TROPA Reposado the leading pick among 15 sipping tequilas, following No. 1 rankings from Next Luxury and Luxury Lifestyle this year. LOS ANGELES, CA, UNITED STATES, October 26, 2026 / EINPresswire.com / -- Drinking Tequila , the tequila education and brand discovery site, has published 15 Of The Best Sipping Tequilas Worth Taking Your Time With (2026 Guide). The guide covers fifteen bottles acr
Oct 26 · 22:55·EIN Presswire
Education
We will pursue every legal avenue available to keep this school open for the families of Canton and the surrounding areas.” — Tamu Green, Founder and President of SR1 CPSA CANTON, MS, UNITED STATES, October 26, 2026 / EINPresswire.com / -- The Mississippi Charter School Authorizer Board (MCSAB) voted today to move toward revoking the charter of SR1 College Preparatory and STEM Academy (SR1 CPSA), the school whose thi
Oct 26 · 22:52·EIN Presswire
AI · Education
Dr. Chris Carson Recognition honors contributions to artificial intelligence, technological innovation and entrepreneurship, including more than a dozen patents SAN FRANCISCO, CA, UNITED STATES, October 26, 2026 / EINPresswire.com / -- Dr. Chris Carson , Founder, Global CEO and Chairman of EchoTwin AI, in addition to his Doctor of Philosophy, has received an honorary Doctor of Technology degree from International Ame
Oct 26 · 22:18·EIN Presswire
Education
Former teacher Farnaz Ehtessabian pilots her tactile, audio-supported algebra cards with a local Boys & Girls Club, plus an English/Spanish classroom workbook. RICHARDSON, TX, UNITED STATES, October 26, 2026 / EINPresswire.com / -- When Farnaz Ehtessabian was teaching algebra, she noticed something that worried her. Her students could find any answer online in seconds, but very little of it stuck. So she went back to
Oct 26 · 22:13·EIN Presswire
Healthcare · Education
New undergraduate and graduate offerings expand academic options in technology, health sciences and behavioral sciences WATERBURY, Conn., Oct. 26, 2026 -- Post University launched seven new undergraduate and graduate degree programs, expanding opportunities for students to...
Oct 26 · 22:09·PR Newswire
Finance · Education
Grant supports real-world budgeting and workforce-readiness education through JA Finance Park DAVENPORT, Iowa, Oct. 26, 2026 -- The American Water Charitable Foundation, a philanthropic nonprofit organization established by American Water (NYSE: AWK), and Iowa American Water...
Oct 26 · 21:57·PR Newswire
Education · Nonprofits
Philanthropic organization advances education and professional development; its inaugural publication covers Puerto Rico’s communications industries. SAN JUAN, PUERTO RICO, PUERTO RICO, October 26, 2026 / EINPresswire.com / -- Fundación Rafael Delgado Márquez (F-RDM) today announced the public launch of its operations and the release of its first book, “Las industrias de la comunicación: Prensa, televisión, cine y re
Oct 26 · 21:55·EIN Presswire
AI · SaaS
Berlin-based Ojin brings real-time AI avatars to corporate learning and development with Human+, giving L&D, sales, and HR leaders one platform to train, certify, and measure conversational skills in more than 70 languages. BERLIN, GERMANY / October 26, 2026 / Ojin, the Human AI Company, today announced
Oct 26 · 21:50·ACCESS Newswire
Healthcare · Education
SOUTH SAN FRANCISCO, Calif., Oct. 26, 2026 -- CERo Therapeutics Holdings, Inc. (OTCQB: CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company advancing engineered T cell therapeutics designed to engage phagocytic mechanisms, today announced that the University of California, Davis (UC Davis), has been activated as a clinical trial site for CERTAIN-T, the Company's ongoing Phase 1 study evaluating CER-1236 in patients with hematologic malignancies. UC Davis also serves as the primary manufacturing site for CER-1236.
Oct 26 · 21:21·GlobeNewswire
SaaS · Healthcare
Wilmington, NC med spa adds the Candela Matrix® platform, combining RF microneedling, fractional resurfacing and bulk heating in one treatment. Safety, results and education guide how new technology is added to the practice. Matrix offers a way to treat texture, tone and laxity with energy delivery that is monitored in real time.” — Aleta Sloan WILMINGTON, NY, UNITED STATES, October 26, 2026 / EINPresswire.com / -- U
Oct 26 · 20:59·EIN Presswire
Finance · Healthcare
International Medtech Executive Brings Extensive Experience in Customer-focused Innovation and Business Transformation
JENA and OBERKOCHEN, GERMANY - October 26, 2026 - Bronwyn Brophy O’Connor, currently CEO of the Vitrolife Group in Sweden, will take over as CEO of Carl Zeiss Meditec AG on December 1, 2026. On the same date, she will join the Executive Board of Carl Zeiss AG with responsibility for the Medical Technology segment. Her appointment as successor to current CEO Andreas Pecher had been first announced in May 2026.
With the start date now confirmed, she will assume leadership of Carl Zeiss Meditec Group from Andreas Pecher, who has served as interim CEO since January 1, 2026.
“I am delighted to join Carl Zeiss Meditec and the ZEISS Group. The company combines deep scientific expertise, close customer relationships and a strong commitment to improving patient care. I look forward to working with our teams and customers to build on these strengths, advance innovation and successfully shape the next stage of the company’s transformation,” said Bronwyn Brophy O’Connor.
"With Bronwyn Brophy O’Connor, Carl Zeiss Meditec is gaining an internationally experienced medtech executive who will bring a strong customer and innovation perspective to the company. We wish her a great start,“ said Peter Kameritsch, Chairman of the Supervisory Board of Carl Zeiss Meditec AG.
"We would like to thank Andreas Pecher, both for his temporary dual role as CEO of the ZEISS Group and interim CEO of Carl Zeiss Meditec AG, and for providing important momentum during this period. With her excellent skills, Bronwyn Brophy O’Connor will now be able to further advance the strategy and transformation of the Medical Technology segment forward and contribute to the success of the ZEISS Group,” said Dr. Michael Bolle, Chairman of the Supervisory Board of Carl Zeiss AG.
Effective December 1, 2026, the Management Board of Carl Zeiss Meditec AG will comprise Bronwyn Brophy O’Connor as CEO and Justus Wehmer as CFO.
The Executive Board of Carl Zeiss AG will comprise Andreas Pecher (President and CEO), Stefan Müller (CFO), Bronwyn Brophy O’Connor (Head of the ZEISS Medical Technology segment), Sven Hermann (Head of the ZEISS Consumer Markets segment), Dr. Frank Rohmund (Head of the ZEISS Semiconductor Manufacturing Technology segment), and Dr. Marc Wawerla (Head of the ZEISS Industrial Quality & Research segment).
Short profiles:
Bronwyn Brophy O’Connor studied at Dublin City University in Ireland. After earning a bachelor’s degree in International Marketing and Languages (Spanish and French), she completed her Master of Business Administration in 2002. She started her career at Johnson & Johnson in 1997, serving in roles of increasing seniority and ending her career there as General Manager of the Cardiovascular Care Group for the U.K. & Ireland in 2012. Bronwyn then joined Covidien, which was later acquired by Medtronic to form the largest medtech company globally. From 2013 until 2018, she first served as Vice President Early Technologies EMEA and later as President Women’s Health at Medtronic in Boston, USA. In 2019, Bronwyn joined Thermo Fisher Scientific as President for the EMEA region and one year later was promoted to Global President of the Immunodiagnostics Division in Uppsala, Sweden. She has worked internationally, including in Ireland, Spain, the U.K., Switzerland, Sweden and the U.S. Since 2023, Bronwyn Brophy O’Connor has been CEO of the Vitrolife Group, a global medtech company publicly listed on the NASDAQ Stockholm and headquartered in Gothenburg, Sweden.
Andreas Pecher studied physics at the University of Würzburg, Germany, and the University of Texas at Austin, USA. He earned a Master of Business Administration (MBA) at the Kellogg School of Management as well as a Master of Engineering Management at the McCormick School of Engineering. He began his career at Motorola (today NXP) in Texas, USA, in 1998. After completing his MBA in 2005, Andreas Pecher worked as a project manager at McKinsey & Company in Germany. Starting in 2010, he headed the Strategy and Business Development department at the solar company Renewable Energy Corporation in Oslo, Norway, and Munich, Germany. In 2013, Andreas Pecher joined the ZEISS Semiconductor Manufacturing Technology (SMT) segment as Head of Strategic Business Development in Oberkochen, Germany. In 2015, he became Head of the Semiconductor Mask Solutions strategic business unit (SMS SBU) and, starting in 2017, headed the Semiconductor Manufacturing Optics strategic business unit. In 2022, Andreas Pecher became Head of the ZEISS SMT segment and was simultaneously appointed a Member of the Executive Board of Carl Zeiss AG. He was named President and CEO of Carl Zeiss AG effective April 1, 2025. In this role, he also took on the interim position as CEO of the publicly listed Carl Zeiss Meditec AG on January 1, 2026, becoming Head of the Medical Technology segment.
Contact for investors and the press
Sebastian Frericks
Head of Group Finance & Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220-116
Email: investors.med@zeiss.com
www.zeiss.com/newsroom
About Carl Zeiss Meditec AG
Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the TecDAX and SDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,784 employees worldwide, the Group generated revenue of EUR 2,228m in fiscal year 2024/25 (to 30 September).
The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG’s shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.
For more information visit our website at www.zeiss.com/med
Oct 26 · 20:58·NewMediaWire